Media
Results from small pancreatic cancer vaccine trial show promise
Pancreatic Cancer UK's Head of Research, Dr Madina Kara comments on early trial results which found seven of the eight people whose immune system responded to a pancreatic cancer vaccine are still alive six years later.
Personal stories behind the breath test trial announcement
Announcing that the world’s first breath test for pancreatic cancer was entering a national clinical trial was one of the most significant milestones in our charity’s history. Its impact was amplified by supporters like Andrew sharing their story.
Pancreatic cancer breath test trial involving thousands of patients launches
A world-first breath test for pancreatic cancer will be trialled nationally on thousands of patients with an unknown diagnosis.
Audit reveals people with pancreatic cancer are waiting too long for treatment costing thousands their chance of survival
New data published in the second annual National Pancreatic Cancer Audit (NPaCA) has revealed that people with pancreatic cancer in England and Wales are waiting too long for treatment to start, contributing to shockingly low treatment rates.
Glasgow scientists to uncover how ‘time bomb’ cysts develop into deadliest common cancer
We have awarded almost £500,000 to researchers at the University of Glasgow to uncover why pancreatic cysts develop into pancreatic cancer.
Seven in ten pancreatic cancer patients taking desperate measures to cope with PERT shortages
We asked our supporters how they are dealing with medicine shortages and uncovered that seven in ten people with pancreatic cancer are taking desperate measures to cope. This leaves them less able to tolerate treatment, with poorer quality of life and at risk of starvation.
Cardiff scientists to discover how pancreatic cancer develops in its early stages
We have awarded almost £100,000 to researchers at Cardiff University to study how changes in a gene called ‘KRAS’ helps the deadliest common cancer develop.
Trial underway in the UK to test a new pancreatic cancer vaccine
A clinical trial of a new vaccine which aims to prevent pancreatic cancer returning after surgery is now underway in Birmingham.
New documentary about Sven-Göran Eriksson
Former manager of the England Men's football team, Sven-Göran Eriksson talks about his pancreatic cancer diagnosis in a new documentary.
Birmingham scientists develop first-of-its-kind ‘ChemoPatch’ to stop pancreatic cancer returning
Researchers at the University of Birmingham have been awarded £87,000 by our organisation to develop a new device which will deliver chemotherapy directly to tissue left behind after surgery reducing the likelihood of the cancer recurring.
Gene ‘switched off’ in early stages of pancreatic cancer, allowing rapid tumour growth and spread
The findings of a research project that we part-funded from Nottingham Trent University has now been announced, with researchers discovering that pancreatic cancer is able to 'switch off' a gene which enables it to become more aggressive.
Pancreatic Cancer UK announced as 2025 TCS London Marathon official charity of the year
Pancreatic Cancer UK is the official charity of the year for the 2025 TCS London Marathon, so "take on the ultimate test to help develop the ultimate test”